Doxapram HCl CAS 7081-53-0

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

7081-53-0

Name

Doxapram HCl

Synonyms

1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate
1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate [ACD/IUPAC Name]
1-Éthyl-4-[2-(4-morpholinyl)éthyl]-3,3-diphényl-2-pyrrolidinone, chlorhydrate, hydrate [French] [ACD/IUPAC Name]
1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinonhydrochloridhydrat [German] [ACD/IUPAC Name]
1-Ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride hydrate
204-022-3 [EINECS]
2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, hydrochloride, hydrate (1:1:1) [ACD/Index Name]
7081-53-0 [RN]
Dopram [Trade name] [Wiki]
Doxapram Hydrochloride
Doxapram Hydrochloride hydrate
Doxapram monohydrochloride monohydrate
P5RU6UOQ5Y
Stimulexin
UNII:P5RU6UOQ5Y
(±)-doxapram hydrochloride monohydrate
[7081-53-0]
113-07-5 [RN]
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one and hydron and chloride and hydrate
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydrate;hydrochloride
1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one;hydron;chloride;hydrate
1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-Pyrrolidinone, monohydrochloride, monohydrate(8CI)
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one hydrate hydrochloride
1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride
1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone hydrate hydrochloride
1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone, hydrochloride, hydrate(1:1:1)
1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-Pyrrolidinone, monohydrochloride, monohydrate (9CI)
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrate hydrochloride
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride monohydrate
1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride–water (1/1)
2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate
2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride, monohydrate
2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-, monohydrochloride, monohydrate
4-[2-(1-ethyl-5-oxo-4,4-diphenylpyrrolidin-3-yl)ethyl]morpholin-4-ium chloride–water (1/1)
Dopram hydrochloride hydrate
Dopram hydrochloride hydrate;Stimulex hydrochloride hydrate;Respiram hydrochloride hydrate
Doxapram (hydrochloride hydrate)
DOXAPRAM HCL
Doxapram hydrochloride monohydrate
Doxapram Hydrochloride Monohydrate 1.0 mg/ml in Methanol (as anhydrous free base)
hydrate
Hydrochloride
HYDROGEN DOXAPRAM HYDRATE CHLORIDE
MFCD09954698
Respiram hydrochloride hydrate
Stimulex hydrochloride hydrate

Molecular Structure

Structure of Doxapram HCl CAS 7081-53-0

Structure of Doxapram HCl CAS 7081-53-0

SMILES

CCN1CC(C(C1=O)(c2ccccc2)c3ccccc3)CCN4CCOCC4.O.Cl

StdInChI

InChI=1S/C24H30N2O2.ClH.H2O/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;;/h3-12,22H,2,13-19H2,1H3;1H;1H2

StdInChIKey

ZOMBFZRWMLIDPX-UHFFFAOYSA-N

Molecular Formula

C24H30N2O2.HCl.H2O

Molecular Weight

432.99

Properties

Appearance

White to off-white crystalline powder

Melting Point

Around 220℃

Safety Data

Symbol

exclamation-mark-jpgGHS06

Signal Word

Danger

Hazard Statements

H301

Precautionary Statements

Missing Phrase – N15.00950417

RIDADR

UN 2811 6.1 / PGIII

WGK Germany

3

Specifications and Other Information of Our Doxapram HCl CAS 7081-53-0

Standard

USP38

Identification Methods

IR,UV

Assay

98.0%~100.5%

Heavy Metals

≤20ppm

pH

3.5~5.0

Loss on Drying

3.0%~4.5%

Residue on Ignition

≤0.3%

Organic Impurities

≤0.2%

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

It is commonly used for respiratory depression caused by central inhibitory drugs, acute respiratory failure, COPD complicated with acute respiratory failure, and accelerated wake-up after anesthesia.

Links

This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/doxapram-hcl-cas-7081-53-0/

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/doxapram-hcl-cas-7081-53-0/

Posted in APIs, Caming Pharmaceutical Ltd, Products